Vanguard and Big Banks Are Buying These 5 Pot Stocks

In a crazy turn of events . . .
Big banks are BUYING shares of pot stocks. These just-released filings reveal the extent of ownership among Canada’s biggest banks.
It’s a bullish signal that marijuana stocks are becoming attractive investments – even for the most conservative financial institutions.
That’s why now’s a crucial time for you to cash in.
Click here to earn 10X bigger profits – with the safest marijuana stocks.
Quarterly filings show extensive buying activity by several top banks.
Bank of Montreal (NYSE: BMO) held a huge stake in Canopy Growth (NYSE: CGC) valued at $54.8 million. The bank had nearly doubled its position in the last three months.
BMO also reported a $1.8 million investment in Tilray (NASDAQ: TLRY) . . . plus $2.7 million in Cronos (NASDAQ: CRON) and $253,000 in GW Pharmaceuticals (NASDAQ: GWPH).
CIBC held an investment in only one cannabis company. The firm reported a $4.2 million investment in Canopy Growth.
These positions are pretty small. But the mere fact that banks are willing to own ANY shares of cannabis stocks is a huge milestone. It shows that they’re comfortable owning these shares and believe in the sector’s growth.
Want to see how a former Wall Streeter trades pot stocks? Click here now.
U.S. mutual fund companies are also jumping into pot stocks.
Back in June, Vanguard reported that it owned 4.1 million shares of Canopy Growth valued at around $164 million.
More recently, the Vanguard Developed Markets Index Fund reported a $41 million investment in Aurora Cannabis (NYSE: ACB) and $16 million in Aphria (NYSE: APHA) stock.
By mid-November, fund companies will report 13F filings with the S.E.C. These filings will give us insights into ownership by additional asset managers.
Big money is jumping into “pot stocks.” That makes right now the best time to earn big profits. Let me show you how . . .
Click here to multiply your pot stock profits.
Yours in Profits,
Ian Wyatt